Follow the people · Insider
Ryan Bond
Ryan Bond files insider transactions with the SEC as a chief strategy officer of Aclarion (ACON). We hold 1 disclosed purchase or sale filed since 25 April 2022, 1 of them in the last 90 days.
- Files forACON
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure17 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 22 April 2022 — 13 August 2026Chief Strategy Officer · Aclarion (ACON)4 Form 4 lines · source: SEC Form 4
Everything they disclosed
4 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 21,122 shares of AclarionSEC Form 417 August 2026Common Stock · traded 13 August 2026 · filed 17 August 2026
- was granted 55,000 shares of AclarionSEC Form 412 June 2026Common Stock · traded 11 June 2026 · filed 12 June 2026
- ▲ bought on the open market 21,000 shares of Aclarion (a derivative holding)SEC Form 425 April 2022Warrants for Common Stock (right to buy) · traded 22 April 2022 · filed 25 April 2022
- ▲ bought on the open market 20,000 shares of AclarionSEC Form 425 April 2022Common Stock · traded 22 April 2022 · filed 25 April 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.